| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3419379 | Revue de Pneumologie Clinique | 2015 | 4 Pages |
Abstract
XDR-TB remains dark prognosis and is almost synonymic of “death sentence” in our countries with limited resources. The application of the international recommendations for tuberculosis management and better accessibility to antituberculous second line drugs would allow to prevent the appearance of such forms of tuberculosis.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
A.S. Bakayoko, B.J.M. Ahui, Z. Kone, A.T.J. Daix, K. Samake, K.M.S. Domoua, E. Aka-Danguy,